These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Challenges in Recruiting Patients to a Controlled Feasibility Study of a Drug for Opioid-Induced Constipation: Lessons From the Population With Advanced Cancer. Bull J; Bonsignore L; Massie L; Riggs A; Knotkova H; Wellman C; Portenoy R J Pain Symptom Manage; 2019 May; 57(5):e5-e8. PubMed ID: 30853551 [No Abstract] [Full Text] [Related]
6. Management of Opioid-Induced Constipation in Patients with Malignancy. Garcia JM; Shamliyan TA Am J Med; 2018 Sep; 131(9):1041-1051.e3. PubMed ID: 29621475 [No Abstract] [Full Text] [Related]
7. GI relief may come sooner than later for patients with chronic noncancer pain. Thompson CA Am J Health Syst Pharm; 2014 Jul; 71(14):1153-5. PubMed ID: 24973366 [No Abstract] [Full Text] [Related]
8. Methylnaltrexone for opioid-induced constipation in advanced illness. Sanz Rubiales A; del Valle Rivero ML N Engl J Med; 2008 Sep; 359(10):1070-1; author reply 1071. PubMed ID: 18768955 [No Abstract] [Full Text] [Related]
9. Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis. Cobo Dols M; Beato Zambrano C; Cabezón Gutiérrez L; Chicas Sett R; Blancas López-Barajas MI; García Navalón F; Fírvida Pérez JL; Serrano Bermúdez G; Togores Torres P; Delgado Mingorance I; Giraldo Marín A; Librán Oriol A; Paredes Lario A; Sánchez Mauriño P; Higuera Gómez O; Moreno Muñoz D; Jiménez López AJ; Huerta González I; Sanz Yagüe A; Soler López B BMJ Support Palliat Care; 2021 Mar; 11(1):25-31. PubMed ID: 32376758 [TBL] [Abstract][Full Text] [Related]
10. Opioid side effects--mechanism-based therapy. Berde C; Nurko S N Engl J Med; 2008 May; 358(22):2400-2. PubMed ID: 18509126 [No Abstract] [Full Text] [Related]
11. Evidence Based Review of Pharmacotherapy for Opioid-Induced Constipation in Noncancer Pain. Murphy JA; Sheridan EA Ann Pharmacother; 2018 Apr; 52(4):370-379. PubMed ID: 29092627 [TBL] [Abstract][Full Text] [Related]
12. ▼Naloxegol for opioid-induced constipation. Drug Ther Bull; 2015 Dec; 53(12):138-40. PubMed ID: 26660436 [TBL] [Abstract][Full Text] [Related]
13. Naloxegol: A Novel Therapy in the Management of Opioid-Induced Constipation. Jones R; Prommer E; Backstedt D Am J Hosp Palliat Care; 2016 Nov; 33(9):875-880. PubMed ID: 26150678 [TBL] [Abstract][Full Text] [Related]
14. [Management of adverse effects of opioid therapy]. Wirz S Z Gastroenterol; 2017 Apr; 55(4):394-400. PubMed ID: 28363231 [TBL] [Abstract][Full Text] [Related]
16. Management of constipation in patients receiving palliative care. Cayley WE Am Fam Physician; 2011 Dec; 84(11):1227-8. PubMed ID: 22150655 [No Abstract] [Full Text] [Related]
17. Naloxegol: A Review of Clinical Trials and Applications to Practice. Dume R; Shuman M Orthop Nurs; 2019; 38(3):209-211. PubMed ID: 31124873 [TBL] [Abstract][Full Text] [Related]
18. Opioid receptors in the GI tract: targets for treatment of both diarrhea and constipation in functional bowel disorders? Pannemans J; Corsetti M Curr Opin Pharmacol; 2018 Dec; 43():53-58. PubMed ID: 30189347 [TBL] [Abstract][Full Text] [Related]
19. Naloxegol (Movantik) for opioid-induced constipation. Med Lett Drugs Ther; 2015 Sep; 57(1478):135-7. PubMed ID: 26393826 [No Abstract] [Full Text] [Related]